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in your element
“We’ll always have Paris” Rick says to Ilsa in their final goodbye on the foggy airstrip of Casablanca 
in the eponymous film. However, the 
question among chemists about the element 
lutetium, named after Lutetia, as the French 
capital was known in Roman times, is not so 
much about having it (it is more abundant 
than silver in the Earth’s crust), but rather 
where to place it on the map.
With its valence electron configuration 
[Xe]4f 146s25d1, element 71 seems to belong 
to group 3, but we often see it placed at 
the very end of the lanthanoid series. Its 
downstairs neighbour lawrencium, for which 
experimental data are much more difficult to 
obtain, is in the same ambiguous situation. So 
which elements should come below scandium 
and yttrium — lutetium and lawrencium, or 
lanthanum and actinium? 
Many periodic tables — including the 
one presented by the International Union of 
Pure and Applied Chemistry (IUPAC) — are 
a bit vague on this point, and the question 
of group-3 membership is currently under 
thorough investigation by an IUPAC project1. 
Meanwhile, the chemical closeness of the 
group-3 and 4f blocks are widely recognized 
and reflected through collective names 
approved by the IUPAC: the ‘lanthanoids’ 
designate the 15 elements from lanthanum to 
lutetium, and the ‘rare-earth metals’ include 
those 15 as well as the unambiguous members 
of group 3, scandium and yttrium.
In any case, lutetium was isolated 
independently by three chemists in 1907, 
from samples composed of mainly an oxide 
of ytterbium, one of the later lanthanoids — 
so it seems fitting for lutetium to also be 
considered part of this gang. There appears 
to have been a heated argument over 
priority between two of the discoverers, 
Georges Urbain and Carl Auer von Welsbach, 
from France and Austria, respectively. The 
third — uncharacteristically for the field — 
kept a low profile, though the US chemist 
Charles ‘King’ James now has a National 
Historic Chemical Landmark dedicated to 
him at the University of New Hampshire.
The International Atomic Weights 
Commission under its chair Frank Clarke 
settled the dispute in 1909. The discovery 
credit was attributed to Urbain and his 
suggested name — lutecium, later to be spelled 
lutetium — was adopted over Welsbach’s 
cassiopeium. Oddly, this was not the end of 
element 71’s role in the naming game. In 2009, 
the name copernicium was proposed for the 
new element 112, but its suggested symbol Cp 
was rejected by IUPAC because it had already 
been used for cassiopeium — which, although 
not official, was used in the German-speaking 
world for a long time; copernicium instead got 
the symbol Cn.
Lutetium is mined together with the 
other rare-earth metals from oxides, but 
is much less abundant, with an average 
yield that is in the range 0.01–1.00%. Water 
solutions will contain colourless Lu3+ ions, 
the only stable oxidation state, with seven 
to nine water molecules coordinated. This 
means that to be useful, coordinating 
ligands need to support high coordination 
numbers, and that is exactly the case for 
motexafin (based on the ‘texaphyrins’), a 
sub-class of porphyrin-like macrocycles 
with five instead of four nitrogen atoms in 
an approximately planar ring. Motexafin 
lutetium, which features Lu3+ and two 
acetate counter-ions coordinated on either 
side of the macrocycle, is potentially a good 
photosensitizer in dynamic phototherapy 
and has been going through phase I trials 
against prostate cancer2.
Uses of the naturally occurring element 
are otherwise scarce, but its isotope Lu-177 is 
successfully used in experimental and clinical 
treatments against some severe cancers by 
hooking it up to a tetraazacyclododecane-
tetraacetate (DOTA) ligand grafted to 
octreotate, a small peptide (pictured). DOTA 
acts as a seven- or eight-coordinating chelator 
whereas octreotate binds to receptors on 
the surfaces of a number of neuroendocrine 
tumour cells, thus directing the ionizing 
radiation of the lutetium isotope into the 
tumour and killing it3,4.
Lutetium is also used, together with 
hafnium, in geological radioactive dating, 
and trace amounts can be analysed by 
neutron activation. This was recently used in 
quantifying rare earths, including lutetium, 
in the sediments of the Bou Regreg River in 
Morocco — not far from Casablanca5. Here’s 
looking at Lu, kid! ❐
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Rounding up lutetium
Lars Öhrström suspects that as time goes by, we may see more of lutetium — the last of the lanthanoids.
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Illustration of a radiolabelled somatostatin 
analogue built using PyMOL (https://pymol.org)  
with a DOTA derivative (PDB: 1NC26, shown 
in black) enclosing lutetium (in lilac), and 
Tyr3–octreotate (PDB: 1YL87); the part of 
octreotate that binds to the receptor is shown in 
turquoise. PDB, protein data bank.
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